HealthcareServices

Lisinopril Market Future Outlook: Strong Growth Expected Toward $2.46 Billion by 2030

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the lisinopril market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Lisinopril Market in 2026, and what figure is it projected to hit by 2030?

The lisinopril market has experienced robust expansion in recent years. Projections indicate this market will expand from $1.87 billion in 2025 to $1.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion has been driven by factors such as the rising incidence of hypertension, the broad clinical acceptance of ACE inhibitors, an expanding aging population, the early integration of the treatment in heart failure management, and wider access to primary healthcare.

The lisinopril market is anticipated to experience substantial growth in the upcoming years. It is projected to reach $2.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. This expansion during the forecast period is attributable to several factors, including the increasing burden of cardiovascular diseases, an escalating demand for economical generic medications, a heightened emphasis on preventive cardiac care, the broadening of treatment for diabetic kidney disease, and increased healthcare expenditure dedicated to managing chronic conditions. Key trends identified for the forecast period encompass the escalating prevalence of hypertension and cardiovascular ailments, a greater dependence on ACE inhibitors for initial treatment, the expansion of generic lisinopril prescriptions, its increasing application in post-heart attack management, and an improvement in long-term treatment adherence within chronic care settings.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

Which Drivers Are Affecting Market Participation In The Lisinopril Market?

The increasing prevalence of Cardiovascular diseases is projected to propel the growth of the lisinopril market going forward. These Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels. The growing prevalence of Cardiovascular diseases can be attributed to several factors, such as population growth and aging, various risk factors, and a lack of implementation of proven prevention and treatment strategies. Lisinopril helps manage Cardiovascular diseases primarily through its ability to lower blood pressure and reduce the strain on the heart and kidneys. This process inhibits the production of angiotensin II, facilitates the dilation of blood vessels, reduces blood volume, and protects organs from damage. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart diseases resulted in 5,302 deaths, showing a slight increase from 5,290 deaths in 2022. Therefore, the increasing occurrence of Cardiovascular diseases is driving the growth of the lisinopril market.

What Segment Categories Are Covered In The Lisinopril Market?

The lisinopril market covered in this report is segmented –

1) By Brand: Prinivil, Zestril, Other Brands

2) By Disease: Hypertension, Heart Failure, Heart Attack

3) By Dosage: Tablet, Liquid

4) By End-Users: Hospitals, Specialty Clinics

Subsegments:

1) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil

2) By Zestril: Different Dosage Forms, Generic Versions Of Zestril

3) By Other Brands: International Brand Variants, Combination Drug Formulations

Which Key Market Players Are Investing In Expansion And Innovation Within The Lisinopril Market?

Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zydus Cadila Healthcare Ltd., Hetero Ltd., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Mylan Pharmaceuticals Inc., Accord Healthcare Ltd., Sandoz International GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

Which Regions Are Projected To Dominate The Lisinopril Market In The Coming Years?

North America was the largest region in the lisinopril market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lisinopril Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16465&type=smp

Browse Through More Reports Similar to the Global Lisinopril Market 2026, By The Business Research Company

Lithium Ion Li Ion Batteries Market Report 2026

https://www.thebusinessresearchcompany.com/report/lithium-ion-li-ion-batteries-global-market-report

Liraglutide Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Lithium Market Report 2026

https://www.thebusinessresearchcompany.com/report/lithium-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795